1. Home
  2. MRSN vs MTEN Comparison

MRSN vs MTEN Comparison

Compare MRSN & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • MTEN
  • Stock Information
  • Founded
  • MRSN 2001
  • MTEN 2015
  • Country
  • MRSN United States
  • MTEN China
  • Employees
  • MRSN N/A
  • MTEN N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • MTEN Building Products
  • Sector
  • MRSN Health Care
  • MTEN Industrials
  • Exchange
  • MRSN Nasdaq
  • MTEN Nasdaq
  • Market Cap
  • MRSN 36.4M
  • MTEN 36.9M
  • IPO Year
  • MRSN 2017
  • MTEN 2024
  • Fundamental
  • Price
  • MRSN $0.35
  • MTEN $4.22
  • Analyst Decision
  • MRSN Buy
  • MTEN
  • Analyst Count
  • MRSN 3
  • MTEN 0
  • Target Price
  • MRSN $4.00
  • MTEN N/A
  • AVG Volume (30 Days)
  • MRSN 3.1M
  • MTEN 168.6K
  • Earning Date
  • MRSN 05-08-2025
  • MTEN 05-21-2025
  • Dividend Yield
  • MRSN N/A
  • MTEN N/A
  • EPS Growth
  • MRSN N/A
  • MTEN N/A
  • EPS
  • MRSN N/A
  • MTEN 0.13
  • Revenue
  • MRSN $40,497,000.00
  • MTEN $9,136,855.00
  • Revenue This Year
  • MRSN N/A
  • MTEN N/A
  • Revenue Next Year
  • MRSN N/A
  • MTEN N/A
  • P/E Ratio
  • MRSN N/A
  • MTEN $32.49
  • Revenue Growth
  • MRSN 9.88
  • MTEN 18.30
  • 52 Week Low
  • MRSN $0.26
  • MTEN $1.81
  • 52 Week High
  • MRSN $3.83
  • MTEN $9.87
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 44.90
  • MTEN N/A
  • Support Level
  • MRSN $0.31
  • MTEN N/A
  • Resistance Level
  • MRSN $0.40
  • MTEN N/A
  • Average True Range (ATR)
  • MRSN 0.05
  • MTEN 0.00
  • MACD
  • MRSN 0.01
  • MTEN 0.00
  • Stochastic Oscillator
  • MRSN 68.09
  • MTEN 0.00

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.

Share on Social Networks: